Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

7792 ARTÍCULOS , VIENDO DEL 3421 AL 3435

Characteristics of respiratory rehabilitation programs for people with Parkinson's disease: a scoping review

Moura Loureiro RF, Santana EDS, Duque FMG, Bernardes RA, Ventura FIQ, Silva RCGD, Oliveira AL, Lima MP, Almeida MLF, Cardoso DFB, Cardoso AFDRM.

JBI Evid Synth. 2025 Jul 1;23(7):1308-1375. doi: 10.11124/JBIES-24-00183. Epub 2025 May 22.

Corrigendum: Parkin characteristics and blood biomarkers of Parkinson's disease in WPBLC study

He H, Xiong X, Zheng Y, Hou J, Jiang T, Quan W, Huang J, Xu J, Chen K, Qian J, Cai J, Lu Y, Lian M, Xie C, Luo J.

Front Aging Neurosci. 2025 May 19;17:1621994. doi: 10.3389/fnagi.2025.1621994. eCollection 2025.

Neurology of Androgens and Androgenic Supplements

Dengri C, Mayberry W, Koriesh A, Nouh A.

Curr Neurol Neurosci Rep. 2025 Jun 3;25(1):39. doi: 10.1007/s11910-025-01426-6.

The neurotoxic threat of micro- and nanoplastics: evidence from In Vitro and In Vivo models

Araújo AM, Mota C, Ramos H, Faria MA, Carvalho M, Ferreira IMPLVO.

Arch Toxicol. 2025 Sep;99(9):3505-3525. doi: 10.1007/s00204-025-04091-3. Epub 2025 Jun 3.

Effectiveness of Telemedicine Interventions on Motor and Nonmotor Outcomes in Parkinson Disease: Systematic Review and Network Meta-Analysis

Dou J, Wang J, Gao X, Wang G, Bai Y, Liang Y, Yang K, Yang Y, Zhang L.

J Med Internet Res. 2025 Jun 3;27:e71169. doi: 10.2196/71169.

No one size fits all approach with apomorphine initiation

Kobylecki C, Ellis RJB.

Parkinsonism Relat Disord. 2025 Sep 30;139 Suppl 1:107889. doi: 10.1016/j.parkreldis.2025.107889. Epub 2025 May 26.

[Research progress on pharmacological effects and mechanism of α-asarone and β-asarone in Acori Tatarinowii Rhizoma]

Wang H, Gao L, Zhang JL, Zhong LY, Jin SH, Chen XY, Zhang W, Wen JW.

Zhongguo Zhong Yao Za Zhi. 2025 May;50(9):2305-2316. doi: 10.19540/j.cnki.cjcmm.20250211.602.

Defining 'OFF' time in device-aided therapy criteria for Parkinson's disease: gaps and opportunities

Bhidayasiri R, Lean PL, Chaudhuri KR.

Parkinsonism Relat Disord. 2025 Sep 30;139 Suppl 1:107894. doi: 10.1016/j.parkreldis.2025.107894. Epub 2025 May 26.

An update on the involvement of inflammatory mediators in Parkinson's disease pathogenesis

Verma O, Faizan M, Goswami S, Singh MP.

Arch Toxicol. 2025 Sep;99(9):3527-3552. doi: 10.1007/s00204-025-04088-y. Epub 2025 Jun 3.

Psychedelics in the Treatment of Neurologic and Psychiatric Disorders: Coincidence or a New Point of View

Lashgari NA, Khalaji M, Rana P, Badrabadi F, Rahnama M, Nasoori H, Momeni Roudsari N, Khosravi Nia MM, Shafaroodi H.

Mol Neurobiol. 2025 Nov;62(11):15070-15092. doi: 10.1007/s12035-025-05097-9. Epub 2025 Jun 4.

Current Approach to Perioperative Evaluation of Neurological Diseases

Ertürk Çetin Ö, Totuk Ö, Güngör Doğan İ, Eryiğit Baran G, Taşdelen B, Darici D, Erci E, Çetin Erci G, Çetinkaya Tezer D, Bekdik P, Adiyeke E, Demir S, Şahin Ş.

Neurologist. 2025 Sep 1;30(5):310-328. doi: 10.1097/NRL.0000000000000632.

Microphysiological engineering of the capillary interface of substantia nigra dopaminergic neurons to study vascular alterations in Parkinson's Disease

Alim A, Baek Y, Lee M, Paek J.

bioRxiv [Preprint]. 2025 May 18:2025.05.14.654131. doi: 10.1101/2025.05.14.654131.

Genetic Code Expansion and Enzymatic Modifications as Accessible Methods for Studying Site-Specific Post-Translational Modifications of Alpha-Synuclein and Tau

Saleh IG, Shimogawa M, Ramirez J, Abakah B, Venkatesh Y, James HP, Li MH, Louie SA, Lougee MG, Chia WK, Cooley RB, Mehl RA, Baumgart T, Mach RH, Eliezer D, Rhoades E, Petersson EJ.

bioRxiv [Preprint]. 2025 May 17:2025.05.16.654576. doi: 10.1101/2025.05.16.654576.

End-product inhibition of the LRRK2-counteracting PPM1H phosphatase

Adhikari A, Tripathi A, Chiang CY, Sherpa P, Pfeffer SR.

bioRxiv [Preprint]. 2025 May 17:2025.05.16.654599. doi: 10.1101/2025.05.16.654599.

Human Applications of Transcranial Temporal Interference Stimulation: A Systematic Review

Demchenko I, Tailor I, Chegini S, Yu H, Gholamali Nezhad F, Rueda A, Kever A, Krishnan S, Datta A, Meltzer JA, Graham SJ, Schweizer TA, Rampersad S, Boyden ES, Violante IR, Chen R, Lozano AM, Bhat V.

medRxiv [Preprint]. 2025 Sep 23:2025.05.16.25327804. doi: 10.1101/2025.05.16.25327804.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias